Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

MYLAN-ALPRAZOLAM

MYLAN PHARMACEUTICALS ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is MYLAN-ALPRAZOLAM discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that MYLAN-ALPRAZOLAM 0.25MG has been permanently discontinued (last updated December 2, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is MYLAN-ALPRAZOLAM not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file5 products
Affected strength0.25MG
Report last updated2017-12-02
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

XANAX

BGP PHARMA ULC

0.25MG · DIN 00548359

Same strengthSame dosage formSame routeNo current shortage

Other Products

PRO-ALPRAZOLAM

PRO DOC LIMITEE

0.5MG · DIN 01908170

Different strengthSame dosage formSame routeNo current shortage

TEVA-ALPRAZOLAM

TEVA CANADA LIMITED

0.5MG · DIN 01913492

Different strengthSame dosage formSame routeNo current shortage

XANAX TS

BGP PHARMA ULC

2MG · DIN 00813958

Different strengthSame dosage formSame routeNo current shortage

APO-ALPRAZ TS

APOTEX INC

2MG · DIN 02243612

Different strengthSame dosage formSame routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02137534

Strength

0.25MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ALPRAZOLAM

See all ALPRAZOLAM products →

Shortage History